Institut Paoli Calmettes; Oncologie Medicale

Marseille 13273

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Renal Cell Carcinoma

Studies at this site

• A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE) — Completed
• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed